Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Robinson

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
Endocrine-Related Cancer|June 25, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needsRamona Dadu, Rozita Bagheri-Yarmand, Matthew D Ringel, et al.
Oncogene|March 6, 2003
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomasDiana E Benn, Michael S Croxson, Kathy Tucker, et al.
Bone|April 29, 2006
Elevated serum FGF23 concentrations in plasma cell dyscrasiasInge Stewart, Claire Roddie, Anthony Gill, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Journal of Neuro-Oncology|November 16, 2007
Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastomaJonathon F Parkinson, Helen R Wheeler, Adele Clarkson, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
Human Pathology|March 19, 2010
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromesAnthony J Gill, Diana E Benn, Angela Chou, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Endocrine-Related Cancer|December 23, 2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumorsMichael A Hahn, Viive M Howell, Anthony J Gill, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Endocrine-Related Cancer|June 25, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needsRamona Dadu, Rozita Bagheri-Yarmand, Matthew D Ringel, et al.
Oncogene|March 6, 2003
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomasDiana E Benn, Michael S Croxson, Kathy Tucker, et al.
Bone|April 29, 2006
Elevated serum FGF23 concentrations in plasma cell dyscrasiasInge Stewart, Claire Roddie, Anthony Gill, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Journal of Neuro-Oncology|November 16, 2007
Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastomaJonathon F Parkinson, Helen R Wheeler, Adele Clarkson, et al.
Clinical Endocrinology|November 3, 2017
Clinical guidance for radioiodine refractory differentiated thyroid cancerMatti L Gild, Duncan J Topliss, Diana Learoyd, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
Human Pathology|March 19, 2010
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromesAnthony J Gill, Diana E Benn, Angela Chou, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2019
RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid CarcinomaLauren Jin Suk Joo, Jocelyn Weiss, Anthony J Gill, et al.
Endocrine-Related Cancer|December 23, 2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumorsMichael A Hahn, Viive M Howell, Anthony J Gill, et al.
Pageof 15